Search results for "gene delivery."

showing 10 items of 95 documents

Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure

1999

BACKGROUND/AIMSReplication deficient recombinant adenoviruses represent an efficient means of transferring genes in vivo into a wide variety of dividing and quiescent cells from many different organs. Although the gastrointestinal tract is a potentially attractive target for gene therapy approaches, only a few studies on the use of viral gene transfer vehicles in the gut have been reported. The prospects of using recombinant adenoviruses for gene delivery into epithelial and subepithelial cells of the normal and inflamed colon are here analysed.METHODSAn E1/E3 deleted recombinant adenovirus (denoted AdCMVβGal) and an adenovirus with modified fibre structure (denoted AdZ.F(pk7)) both express…

ColonT cellGenetic enhancementGenetic VectorsGene ExpressionBiologyGene deliverymedicine.disease_causeRecombinant virusArticleAdenoviridaeMiceAdministration RectalGene expressionmedicineAnimalsHumansReporter geneLamina propriaMice Inbred BALB CGastroenterologyGene Transfer TechniquesDefective VirusesColitisInflammatory Bowel Diseasesbeta-GalactosidaseVirologyMolecular biologyAdenoviridaemedicine.anatomical_structureInjections IntravenousInjections Intraperitoneal
researchProduct

Dendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy.

2021

Gene-directed enzyme prodrug therapy (GDEPT) has been intensively studied as a promising new strategy of prodrug delivery, with its main advantages being represented by an enhanced efficacy and a reduced off-target toxicity of the active drug. In recent years, numerous therapeutic systems based on GDEPT strategy have entered clinical trials. In order to deliver the desired gene at a specific site of action, this therapeutic approach uses vectors divided in two major categories, viral vectors and non-viral vectors, with the latter being represented by chemical delivery agents. There is considerable interest in the development of non-viral vectors due to their decreased immunogenicity, higher…

DrugDendrimersmedicine.medical_treatmentmedia_common.quotation_subjectGenetic VectorsPharmaceutical ScienceEnzyme TherapyComputational biologyReviewdendrimerdelivery vehiclesAnalytical ChemistryTargeted therapyViral vectornon-viral vectorQD241-441DendrimerGDEPTDrug DiscoverymedicineAnimalsHumansProdrugsPhysical and Theoretical ChemistryGenemedia_commonchemistry.chemical_classificationGDEP therapyImmunogenicityOrganic ChemistrytransgeneGene Transfer TechniquesGenetic TherapyProdrugtargeted therapyEnzymesEnzymechemistrygene delivery systemChemistry (miscellaneous)Molecular MedicineNanoparticlesMolecules (Basel, Switzerland)
researchProduct

Polymer therapeutics—polymers as drugs, drug and protein conjugates and gene delivery systems: Past, present and future opportunities

2006

As the 21st century begins we are witnessing a paradigm shift in medical practice. Whereas the use of polymers in biomedical materials applications, for example as prostheses, medical devices, cont...

Drugchemistry.chemical_classificationPolymersbusiness.industrymedia_common.quotation_subjectPharmaceutical ScienceMedical practiceNanotechnologyGenetic TherapyPolymerModels TheoreticalPharmacologyGene deliveryTransfectionDrug Delivery SystemsPharmaceutical PreparationschemistryHumansMedicineCarrier Proteinsbusinessmedia_commonJournal of Drug Targeting
researchProduct

Nanocarriers for respiratory diseases treatment: Recent advances and current challenges

2014

Pulmonary delivery of locally-acting drugs encapsulated in nanocarriers provides several advantages for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary diseases, cystic fibrosis, tuberculosis and lung cancer. These advantages include, among others, sustained drug delivery to the lungs, reduced therapeutic dose and improved patient compliance. The aim of this review is to give an updated overview on recent advances recorded in the last few years in this field as well as on the major challenges still existing and that remain to be overcome before any clinical application. After an outline on the cellular and extracellular barriers affecting drug delivery to…

Drugmedicine.medical_specialtymedia_common.quotation_subjectpulmonary deliveryAntitubercular AgentsMicrobial Sensitivity TestsGene deliveryPharmacologyCystic fibrosisTherapeutic indexDrug DiscoverymedicineAnimalsHumansTuberculosisIntensive care medicinemedia_commonDrug CarriersLungrespiratory diseasesbusiness.industryMycobacterium tuberculosisGeneral Medicinemedicine.diseaseinhalation of polymeric- and lipid-based nanocarriermedicine.anatomical_structurelung targetingTargeted drug deliveryDrug deliverymucus penetrationNanoparticlesNanocarriersbusinessDefense mechanism
researchProduct

Flotillin-involved uptake of silica nanoparticles and responses of an alveolar-capillary barrier in vitro

2013

AbstractDrug and gene delivery via nanoparticles across biological barriers such as the alveolar-capillary barrier of the lung constitutes an interesting and increasingly relevant field in nanomedicine. Nevertheless, potential hazardous effects of nanoparticles (NPs) as well as their cellular and systemic fate should be thoroughly examined. Hence, this study was designed to evaluate the effects of amorphous silica NPs (Sicastar) and (poly)organosiloxane NPs (AmOrSil) on the viability and the inflammatory response as well as on the cellular uptake mechanisms and fate in cells of the alveolar barrier. For this purpose, the alveolar epithelial cell line (NCI H441) and microvascular endothelial…

EndosomeCell SurvivalLipid BilayersPharmaceutical ScienceGene deliverysilica nanoparticlesEndocytosisClathrinNP transportCell LineDrug Delivery SystemsAlveolar-capillary barrierAlveolar capillary barrierElectric ImpedanceHumansColoring AgentsInflammationFlotillin-1/-2-dependent uptake/traffickingbiologyChemistryRhodaminesVesicleMicrocirculationEndothelial CellsMembrane ProteinsGeneral Medicinerespiratory systemSilicon DioxideNP uptakeIn vitroCoculture TechniquesEndocytosisCapillariesEndothelial stem cellPulmonary AlveoliNP-transportNanomedicineCell cultureImmunologybiology.proteinBiophysicsNanoparticlesBiotechnologyEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Improvement in Nuclear Entry and Transgene Expression of Baculoviruses by Disintegration of Microtubules in Human Hepatocytes

2005

ABSTRACT Autographa californica multicapsid nucleopolyhedrovirus (AcMNPV), a potent virus for mammalian cell gene delivery, possesses an ability to transduce mammalian cells without viral replication. We examined the role of the cellular cytoskeleton in the cytoplasmic trafficking of viral particles toward the nucleus in human hepatic cells. Microscopic studies showed that capsids were found in the nucleus after either viral inoculation or cytoplasmic microinjection of nucleocapsids. The presence of microtubule (MT) depolymerizing agents caused the amount of nuclear capsids to increase. Overexpression of p50/dynamitin, an inhibitor of dynein-dependent endocytic trafficking from peripheral e…

EndosomeMicrotubule-associated proteinvirusesImmunologyEndocytic cycleGenetic VectorsActive Transport Cell NucleusGene ExpressionBiologyGene deliveryMicrobiologyMicrotubulesCell Linechemistry.chemical_compoundTransduction GeneticVirologyHumansNucleocapsidCytoskeletonDynactin Complexbeta-GalactosidaseMolecular biologyNucleopolyhedrovirusesRecombinant ProteinsVirus-Cell InteractionsNocodazoleMicroscopy ElectronViral replicationchemistryLac OperonCell cultureCytoplasmInsect ScienceHepatocytesMicrotubule-Associated Proteins
researchProduct

Novel Biocompatible Cationic Copolymers Based on Polyaspartylhydrazide Being Potent as Gene Vector on Tumor Cells

2007

Introduction. The reaction between !,"-poly(aspartylhydrazide) (PAHy), a water soluble synthetic polymer and 3-(carboxypropyl)trimethyl-ammonium chloride (CPTACl) produced copolymers bearing permanent positive charges (PAHy–CPTA) with molecular weight of 10 kDa and PAHy–CPTA copolymers differing in positive charge amount (18–58%) were chosen for biological investigations. Materials and methods. Biophysical properties of DNA/PAHy–CPTA polyplexes were evaluated in terms of DNA condensation, zeta potential and size distribution. Cytotoxicity studies on Neuro2A murine neuroblastoma cells evidenced absence of toxicity of these copolymers up to 300 2g/ml unlike linear polyethylenimine (LPEI) that…

Erythrocyte AggregationBiocompatibilityCell SurvivalPolymersPharmaceutical ScienceBiocompatible MaterialsBiologyTransfectionDNA condensationMiceNeuroblastomachemistry.chemical_compoundIn vivoCationsCell Line TumorZeta potentialAnimalsPolyethyleneiminePharmacology (medical)Particle SizeCytotoxicityPharmacologyPolyethylenimineCytotoxicity liver toxicity nonviral gene delivery transfectionDose-Response Relationship DrugLiver DiseasesBody WeightOrganic ChemistryGenetic transferDNATransfectionMolecular WeightLiverchemistryBiochemistryNucleic Acid ConformationMolecular MedicineFemaleChemical and Drug Induced Liver InjuryPeptidesBiotechnologyPharmaceutical Research
researchProduct

Microwave-assisted synthesis of PHEA-oligoamine copolymers as potential gene delivery systems

2009

Aims - Copolymers bearing oligoamines and having buffering capacity in the endosomal pH range seems very promising as non viral vectors in gene delivery, due to the great importance of endosomal escaping for an efficient endocellular DNA release. Aim of this paper was to prepare new copolymers based on α,β-poly-(N-2-hydroxyethyl)-D,L-aspartamide (PHEA) as polymeric backbone and bearing an oligoamine, such as diethylentriamine (DETA) in the side chain and useful for gene delivery. Moreover in order to reduce solvent volume and to make faster the reaction, microwave-assisted has been used. Materials and methods - PHEA copolymers bearing different amount of DETA were prepared by using bis(4-ni…

Erythrocyte AggregationMaterials scienceCell SurvivalPolymersBiomedical EngineeringMedicine (miscellaneous)Bioengineeringmicrowave-assisted synthesis PHEA polycationDevelopmentGene deliveryHemolysisMicrowave assistedpolyhydroxyethylaspartamideNitrophenolsMicechemistry.chemical_compoundPlasmid dnaCell Line TumorPolymer chemistryPolyaminesSide chainCopolymerAnimalsHumansGeneral Materials Sciencegene deliveryMicrowavesDerivatizationPolyhydroxyethyl MethacrylateDETA diethyltriamineGene Transfer TechniquesDNACombinatorial chemistrySolventchemistryDiethylenetriamine
researchProduct

New pegylated polyaspartamide-based polyplexes as gene delivery vectors

2010

Aims: To synthesize novel polyhydroxyethylaspartamide (PHEA) copolymers containing spermine (Spm) and polyethylene glycol (PEG) moieties in high yields, with the expectation that this material would show stealth properties and the ability to complex DNA by electrostatic interactions. Materials & methods: PHEA–PEG–Spm copolymer was prepared with a two-step reaction. Chemical, physicochemical and biological characterizations of PHEA–PEG–Spm copolymers and their obtained polyplexes with pDNA were performed. Results: The introduction of spermine in PHEA structure allows to obtain a copolymer bearing in the side chains polyamine moieties capable to interact with DNA. On the other hand, the …

ErythrocytesMaterials scienceBiocompatibilityGenetic VectorsStatic ElectricityGENE DELIVERY VECTORS POLYPLEXES NANOMEDICINE.Melanoma ExperimentalBiomedical EngineeringMedicine (miscellaneous)SpermineBioengineeringPolyethylene glycolDevelopmentGene deliveryPolyethylene GlycolsElectrolytesMicechemistry.chemical_compoundPolymer chemistryPEG ratioPolyaminesSide chainCopolymerAnimalsHumansNanotechnologyGeneral Materials SciencefungiGene Transfer Techniquestechnology industry and agricultureDNACombinatorial chemistryModels ChemicalchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSperminePeptidesPolyamineNanomedicine
researchProduct

NEW PEGYLATED POLYHYDROXYETHYLASPARTAMIDE-SPERMINE COPOLYMER AS GENE DELIVERY SYSTEM

2009

GENE DELIVERY polyhydroxyethylaspartamideSettore CHIM/09 - Farmaceutico Tecnologico Applicativo
researchProduct